CautionSeroxat

Paroxetine

SSRI with anticholinergic action

Avoid in pregnancy where alternatives exist (T1 cardiac risk).

Oral

First-line for

  • OCD, PTSD — when other SSRIs failed and pregnancy is not planned

Mechanism

SERT inhibition + weak muscarinic antagonism → sedating profile, more discontinuation syndrome than other SSRIs.

"Paroxetine = Preventable T1 cardiac risk"

  • Absolute cardiac malformation risk +0.5–1% (T1)
  • Withdraw slowly — worst SSRI for discontinuation
  • Switch preconception to sertraline

Dosing

Depression
20 mg OD; max 50 mg
OCD
40 mg OD; max 60 mg

Contraindications

  • AbsoluteConcurrent MAOI
  • CautionPlanned or confirmed T1 pregnancy

Side effects

  • Anticholinergic (dry mouth, constipation)
  • Weight gain
  • Sexual dysfunction
  • Marked discontinuation syndrome

Fetal & maternal notes

  • T1 exposure: OR 1.5–2 for cardiac defects (VSD/ASD)
  • Neonatal adaptation and PPHN like other SSRIs

Key interactions

  • Tamoxifen

    Avoid

    Potent CYP2D6 inhibition ↓ endoxifen — AVOID

  • MAOIs, linezolid, tramadol

    Avoid

    Serotonin syndrome

Clinical pearls

  • 💡 If a woman becomes pregnant on paroxetine, do not stop abruptly — plan careful switch or continue if benefits > risks
  • 💡 Fetal echocardiogram at 20 weeks if T1 exposure

Content last reviewed: REPLACE_ME (e.g. 2026-07)

Spotted something out of date? See our disclaimer or use Report an Error above.

For educational use only

Not medical advice. Verify dosing against the BNF and your local trust guidelines before prescribing.